L3VLUP
ProSign in

IRWD · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

IRWDJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • IRWD
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterIRWDJNJ
Q3 20207 holders, $251m30 holders, $26.2bn
Q4 20207 holders, $302m32 holders, $26.6bn
Q1 20213 holders, $272m31 holders, $25.3bn
Q2 20216 holders, $331m37 holders, $25.6bn
Q3 20213 holders, $236m40 holders, $24.1bn
Q4 20214 holders, $251m33 holders, $25.2bn
Q1 20223 holders, $240m35 holders, $28.2bn
Q2 20223 holders, $236m33 holders, $26.9bn
Q3 20224 holders, $204m36 holders, $25.4bn
Q4 20228 holders, $287m35 holders, $27.6bn
Q1 20236 holders, $108m42 holders, $24.5bn
Q2 20238 holders, $161m38 holders, $25.0bn
Q3 20235 holders, $108m37 holders, $18.9bn
Q4 20237 holders, $147m31 holders, $19.0bn
Q1 20245 holders, $108m32 holders, $19.7bn
Q2 20244 holders, $83m35 holders, $20.4bn
Q3 20242 holders, $35m28 holders, $22.3bn
Q4 20243 holders, $41m37 holders, $20.4bn
Q1 20251 holders, $19k32 holders, $20.5bn
Q2 20251 holders, $9k31 holders, $18.4bn
Q3 20251 holders, $17k32 holders, $23.7bn
Q4 20253 holders, $49m29 holders, $27.8bn
Q1 20262 holders, $23m34 holders, $35.6bn
Q2 20262 holders, $58m33 holders, $39.1bn
IRWD

Ironwood Pharmaceuticals Inc

Holders
7
Reported value
$147m
Buyers
5
Sellers
2

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only IRWD (3)

Brevan Howard Capital Management LP, First Eagle Investment Management LLC, Point72 Asset Management LP

Only JNJ (27)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Quantbot Technologies LP, Squarepoint Ops LLC, Susquehanna International Group LLP, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC, and 2 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →